Bilateral Spontaneous Pneumothorax in a Young Gentleman
Albert Teng1, Tzy Harn Chua2, Chun Yuen Chow2
1Department of Respiratory and Critical Care Medicine Singapore General Hospital Singapore Singapore.
Respirology Case Reports
|October 1, 2025
Summary
Bilateral spontaneous pneumothorax in young smokers can indicate pulmonary Langerhans cell histiocytosis (PLCH). Early diagnosis and smoking cessation are crucial for managing this rare cystic lung disease.
Area of Science:
- Pulmonology
- Thoracic Surgery
- Pathology
Background:
- Bilateral spontaneous pneumothorax is a rare condition, often associated with underlying lung disease.
- Young smokers presenting with pneumothorax warrant investigation for underlying cystic lung pathologies.
- Pulmonary Langerhans cell histiocytosis (PLCH) is an uncommon cystic lung disease.
Purpose of the Study:
- To report a case of bilateral spontaneous pneumothorax in a young smoker.
- To highlight the diagnostic challenges and features of PLCH.
- To emphasize the importance of prompt diagnosis and management.
Main Methods:
- Case report of a 26-year-old male with bilateral pneumothorax.
- Diagnostic workup included chest radiography, high-resolution computed tomography (HRCT), and surgical lung biopsy.
- Treatment involved bilateral chest tube insertion, video-assisted thoracoscopic surgery (VATS) with bullectomy, pleurodesis, and biopsy.
Main Results:
- Chest radiography confirmed bilateral pneumothoraces.
- HRCT revealed multiple bilateral thin-walled cysts with lung base sparing and peripheral nodules.
- Histopathology confirmed PLCH with Langerhans cells and eosinophilic infiltration.
Conclusions:
- Young smokers with spontaneous bilateral pneumothorax should be evaluated for PLCH.
- Radiologic and histopathologic findings are essential for diagnosing cystic lung diseases like PLCH.
- Smoking cessation is the primary management strategy for PLCH.
Related Concept Videos
Pneumothorax-II
916
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
916
Pneumothorax-I
1.2K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.2K
Pulmonary Cycle: Exhalation
3.0K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
3.0K
Flail Chest-II
538
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
538
Pleural Effusion I: Introduction
4.0K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
4.0K
Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K


